腾讯健康上线新冠疫苗接种便民服务专区
据《中国证券报》报道,近日,按照国家的统一部署,各地陆续对重点人群开展了新冠病毒疫苗接种工作。为了让公众第一时间了解疫苗预约接种服务,腾讯健康上周六(26日)正式上线新冠疫苗接种便民服务专区,整理收录了全国各地官方新冠疫苗紧急接种预约登记的入口,为有接种需求的人群提供接种政策、预约接种入口、接种点查询,以及新冠疫苗科普等便民服务。
打开手机微信-我的-支付,点击「医疗健康」,或者直接在微信顶部搜索「腾讯健康」小程序,进入「腾讯健康-疫苗-新冠肺炎疫苗」即可找到新冠疫苗接种便民服务专区。目前,市民可以方便地查询到全国6个省11个城市新冠疫苗紧急接种点的地址、接种服务时间、联系电话等信息。
疫情暴发以来,腾讯健康陆续上线「新冠肺炎疫情服务平台」、「新冠肺炎疫苗专区」等平台工具,为全国各省市卫健委、区县卫健局和疾控中心、医疗机构和个人等提供疫情服务工具,与全社会共同抗疫。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.